Should You Consider Investing in Ligand Pharmaceuticals (LGND)?
Bumbershoot Holdings LP, an investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here. Bumbershoot Holdings L.P.
Ligand Pharmaceuticals Inc (LGND)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 20,472,000 | $19,704 | +1% | 0.22% | |
| 2. | Impax Asset Management Ian Simm | 184,320 | $16,445 | +13% | 0.08% |
| 3. | Stonepine Capital Timothy P. Lynch | 100,244 | $8,944 | +37% | 4.16% |
| 4. | Millennium Management Israel Englander | 79,410 | $7,085 | -40% | 0% |
| 5. | 57,100 | $5,094 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.76 | 2,500 | Officer | 173,354 | 2022-05-13 | Filing | |
| $82.52 | 1,000 | Director | 28,190 | 2020-11-02 | Filing | |
| $87.01 | 750 | Director | 67,203 | 2019-09-03 | Filing | |
| $86.18 | 500 | Officer | 17,151 | 2019-09-03 | Filing | |
| $90.01 | 746 | Director | 66,453 | 2019-08-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $102.62 | 908 | Director | 41,209 | 2022-02-28 | Filing | |
| $161.86 | 4,835 | Director | 25,398 | 2021-11-16 | Filing | |
| $160.50 | 3,000 | Officer, Director | 335,095 | 2021-11-12 | Filing | |
| $163.02 | 11,160 | Officer | 166,525 | 2021-11-11 | Filing | |
| $109.67 | 8,840 | Officer | 164,355 | 2021-08-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 17,621 | $1,572,147 | 0% | |
| 2. | 4,281 | $381,951 | 0% | |
| 3. | 2,704,847 | $241,323 | 0% | |
| 4. | 1,773,974 | $158,274 | 0% | |
| 5. | 1,389,488 | $123,970 | 0.08% |
News See All
Hedge Fund and Insider Trading News: Michael Burry, Chris Hohn, Fortress Investment Group, Magnetar Capital, Verde Asset Management, Lemelson Capital Management, Evli Factor Premia Fund, Renovacor Inc (RCOR), Assurant, Inc. (AIZ), and More
NEW YORK--(BUSINESS WIRE)-- Fortress Investment Group LLC (“Fortress”) was named the recipient of the inaugural “Diversity and Inclusion Achievement” award at the 2021 HFM US Performance Awards...
Here's Why Ligand Pharmaceuticals (LGND) Became Wasatch Global's Q1 2021 Top Contributor
Wasatch Global Investors, an investment management firm, published its “Wasatch Core Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
Is LGND A Good Stock To Buy According To Hedge Funds?
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)
Timothy P. Lynch’s Stonepine Capital is a life science-focused hedge fund that seeks to utilize its industry experience to uncover undervalued and under-the-radar health companies.
Should I Avoid Ligand Pharmaceuticals Inc. (LGND)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Were Hedge Funds Right About Ligand Pharmaceuticals Inc. (LGND)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: Kyle Bass, Steve Cohen, Cheyne Capital, Worm Capital, Broadcom Inc (AVGO), Ligand Pharmaceuticals Inc. (LGND), and More
Steve Cohen hasn’t given up on buying the New York Mets.
Hedge Funds Piling Into Ligand Pharmaceuticals Inc. (LGND) Again
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Are Betting On Ligand Pharmaceuticals Inc. (LGND)
We hate to say this but, we told you so.
Billionaire Hedge Funds
